Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06204523Unknown

Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

Role: collaborator

NCT04681703Not ApplicableCompleted

Nurse-led Program Efficacy on Blood Pressure Control

Role: lead

NCT04321473Unknown

Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention

Role: collaborator

NCT03731884Unknown

Proteomic Profiling of Coronary Thrombus in Acute Myocardial Infarction

Role: collaborator

NCT02196272Not ApplicableUnknown

Nurse-led Reminder Program for Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients

Role: lead

NCT01041768Not ApplicableUnknown

Multicentric Prospective Randomized Trial on Surgery Versus Standard Medical Care in Type 2 Diabetic Patients BMI 30-35

Role: collaborator

All 6 trials loaded